Rare diseases
Investigational molecules
Locations
Study of Niraparib and Dostarlimab for Children with Recurrent or Hard-to-Treat Solid Tumors
CzechiaStudy on the Effects of Human Albumin Solution and Electrolyte Drug Combination for Fluid Therapy in Patients Undergoing Laparoscopic Surgery
SwedenStudy of Pembrolizumab, Olaparib, and Pemetrexed for Patients with Stage IV Non-Small Cell Lung Cancer
AustriaStudy on the Effectiveness of Carboplatin and Olaparib for Patients with Triple-Negative Breast Cancer with Positive HRD Status
AustriaStudy of Eliglustat alone or with imiglucerase in children and adolescents aged 2-17 years with Gaucher disease type 1 and type 3
FranceStudy on L-Carnitine and Cobamamide for Patients with Septic Shock and Acute Kidney Injury
FranceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
BulgariaStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
BelgiumStudy on the Effect of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Stage III Ovarian Cancer Patients Undergoing Surgery
DenmarkStudy on the Safety and Effectiveness of ADX-914 for Patients with Moderate to Severe Atopic Dermatitis
PolandStudy of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
